Key points are not available for this paper at this time.
WHO now plans to work with global, regional and national research funding agencies to catalyse the investment needed to enable teams to pursue these research priorities in medication safety across high-, middle- and low-resource country settings.
Sheikh et al. (Wed,) studied this question.